Advertisement

Topics

Vital Art and Science Announces License Agreement with Genentech for Its mVT® Service

09:00 EDT 19 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Vital Art and Science, LLC, developer of the only FDA cleared app used to conduct home vision monitoring of patients with maculopathy, will provide its mVT® App for use in Genentech clinical trials investigating new ophthalmic ...

Other Sources for this Article

Vital Art and Science, LLC
George Mavro, CMO
844-267-8019

NEXT ARTICLE

More From BioPortfolio on "Vital Art and Science Announces License Agreement with Genentech for Its mVT® Service"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...